Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Curaleaf CEO said DEA has until end of April 2024 to
View:
Post by subaru1i on Jan 27, 2024 9:12am

Curaleaf CEO said DEA has until end of April 2024 to

deschedule cannabis from 1 to 3.  Can anyone else confirm this?
Comment by subaru1 on Jan 27, 2024 2:54pm
In that context, DEA’s response offered little insight, with the agency declining to address the lawmakers’ key arguments and instead simply outlining the procedural details of the scheduling review. It also did not divulge any details about the timeline for the completion of the review, though many observers expect it to wrap up ahead of the November election. Published 3 weeks ago.
Comment by subaru1i on Jan 27, 2024 3:32pm
Thank you.  The request came from the White House, descheduling is a hot topic issue in the U.S. with over 65% of the population in favor of full legalization as well.   If the DEA drags their feet too long, before the election, Biden as President has the full authority to appoint a NEW head to the DEA so that it WILL be rescheduled ONE WAY OR ANOTHER!!! You have the White House ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities